The Oncology Institute Reports Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023
Go back to The Oncology Institute Reports Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023| TARGETS Trust XXIV 7% TARGETS with respect to the common stock of Intel Corporation (NASDAQ: TOI) | Delayed: 5.03 +0.02 (0.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.01 | 52 Week High | $7.47 | |||
| Open | $4.90 | 52 Week Low | $7.47 | |||
| Day High | $5.19 | P/E | N/A | |||
| Day Low | $4.90 | EPS | $0.00 | |||
| Volume | 1,155,399 | |||||
| (NASDAQ: TOIIW) | Delayed: 0.04 -0.02 (33.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.06 | 52 Week High | $ | |||
| Open | $0.04 | 52 Week Low | $ | |||
| Day High | $0.04 | P/E | N/A | |||
| Day Low | $0.04 | EPS | $ | |||
| Volume | 6,600 | |||||
